Answers are grounded in this paper and cite their sources.
New human β-glucocerebrosidase (GCase) ligands with rigid 1,6-anhydro-β-L-idonojirimycin cores have been designed with the aid of molecular modeling. Efficient pharmacological chaperones for the L444P (trafficking-incompetent) mutant GCase enzyme associated with type 2 and 3 Gaucher disease (GD) were identified.
No takes yet. Share an insight, caveat, or question.
Alfonso et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: